Interval of less than 5 years between the first and second operation is a risk factor for a third operation for Crohn's disease

Inflammatory Bowel Diseases

Volumn 18, Issue 1, 2012, Pages 17-24

  Watanabe, Toshiaki ^a   Sasaki, Iwao ^b   Sugita, Akira ^c   Fukushima, Kohei ^b   Futami, Kitaro ^d   Hibi, Toshifumi ^e   Watanabe, Mamoru ^f  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AKITA UNIVERSITY   (Japan)

^d Fukuoka University Chikushi Hospital   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Crohn's disease; reoperation; risk factor; second surgery; surgery; time changes; time trend

Indexed keywords

INFLIXIMAB;

ADOLESCENT; ADULT; ARTICLE; CHILD; COLORECTAL DISEASE; CROHN DISEASE; DISEASE DURATION; FEMALE; HUMAN; ILEOCECAL VALVE; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; SCHOOL CHILD; SMALL INTESTINE DISEASE; TIME;

ADOLESCENT; ADULT; CHILD; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REOPERATION; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 83455247400     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21671     Document Type: Article

References (38)

1. Farmer RG, Whelan G, Fazio VW,. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology. 1985; 88: 1818-1825. (Pubitemid 15052293)
2. Simillis C, Yamamoto T, Reese GE, et al. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus non-perforating CD. Am J Gastroenterol. 2008; 103: 196-205.
3. Yamamoto T, Fazio VW, Tekkis PP,. Safety and efficacy of strictureplasty for CD: a systematic review and meta-analysis. Dis Colon Rectum. 2007; 50: 1968-1986. (Pubitemid 350077088)
4. Williams JG, Wong WD, Rothenberger DA, et al. Recurrence of CD after resection. Br J Surg. 1991; 78: 10-19.
5. Higgens CS, Allan RN,. Crohn's disease of the distal ileum. Gut. 1980; 21: 933-940. (Pubitemid 11213466)
6. Sachar DB,. Patterns of postoperative recurrence in Crohn's disease. Scand J Gastroenterol Suppl. 1990; 172: 35-38. (Pubitemid 20206664)
7. Bernell O, Lapidus A, Hellers G,. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal CD. Br J Surg. 2000; 87: 1697-1701.
8. Velayos FS, Sandborn WJ,. Use of azathioprine and 6MP in postoperative Crohn's: changing natural history or just along for the ride? Am J Gastroenterol. 2009; 104: 2097-2099.
9. Bernell O, Lapidus A, Hellers G,. Risk factors for surgery and postoperative recurrence in CD. Ann Surg. 2000; 231: 38-45. (Pubitemid 30043937)
10. Yamamoto T,. Factors affecting recurrence after surgery for CD. World J Gastroenterol. 2005; 11: 3971-3979.
11. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in CD: evidence for two clinical forms. Gut. 1988; 29: 588-592.
12. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of CD. Gastroenterology. 1990; 98: 1123-1128.
13. Sachar DB, Wolfson DM, Greenstein AJ, et al. Risk factors for postoperative recurrence of CD. Gastroenterology. 1983; 85: 917-921.
14. Alves A, Panis Y, Joly F, et al. Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease? Inflamm Bowel Dis. 2004; 10: 491-495. (Pubitemid 39276454)
15. Yao T, Matsui T, Hiwatashi N,. CD in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000; 43: S85-93.
16. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of CD remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology. 2004; 127: 723-729. (Pubitemid 39208405)
17. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for CD. Gastroenterology. 2004; 127: 730-740. (Pubitemid 39208406)
18. D'Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of CD: a controlled randomized trial. Gastroenterology. 2008; 135: 1123-1129.
19. Blum E, Katz JA,. Postoperative therapy for CD. Inflamm Bowel Dis. 2009; 15: 463-472.
20. Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in CD: a meta-analysis. Am J Gastroenterol. 2009; 104: 2089-2096.
21. Herfarth H, Tjaden C, Lukas M, et al. Z T-1 Study Group. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of CD. Gut. 2006; 55: 1525-1526. (Pubitemid 44476806)
22. Domènech E, Mañosa M, Bernal I, et al. Impact of azathioprine on the prevention of postoperative CD recurrence: results of a prospective, observational, long-term follow-up study. Inflamm Bowel Dis. 2008; 14: 508-513. (Pubitemid 351571830)
23. Vermeire S, van Assche G, Rutgeerts P,. Review article: altering the natural history of CD-evidence for and against current therapies. Aliment Pharmacol Ther. 2007; 25: 3-12. (Pubitemid 44902859)
24. Yamamoto T, Umegae S, Matsumoto K,. Impact of infliximab therapy after early endoscopic recurrence following ileocolic resection of CD: a prospective pilot study. Inflamm Bowel Dis. 2009; 15: 1460-1466.
25. Regueiro M, Schraut W, Baidoo L, et al. Infliximab prevents CD recurrence after ileal resection. Gastroenterology. 2009; 136: 441-450.
26. Rubenstein JH, Chong RY, Cohen RD,. Infliximab decreases resource use among patients with CD. J Clin Gastroenterol. 2002; 35: 151-156. (Pubitemid 34815854)
27. Sorrentino D, Terrosu G, Avellini C, et al. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolic Crohn disease. Arch Intern Med. 2007; 167: 1804-1807. (Pubitemid 47403070)
28. Poggioli G, Laureti S, Selleri S, et al. Factors affecting recurrence in Crohn's disease. Results of a prospective audit. Int J Colorectal Dis. 1996; 11: 294-298.
29. Sachar DB, Wolfson DM, Greenstein AJ, et al. Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology. 1983; 85: 917-921. (Pubitemid 13000646)
30. Griffiths AM, Wesson DE, Shandling B, et al. Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut. 1991; 32: 491-495.
31. Greenstein AJ, Sachar DB, Pasternack BS, et al. Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med. 1975; 293: 685-690.
32. Raab Y, Bergström R, Ejerblad S, et al. Factors influencing recurrence in Crohn's disease. An analysis of a consecutive series of 353 patients treated with primary surgery. Dis Colon Rectum. 1996; 39: 918-925. (Pubitemid 26332470)
33. Anseline PF, Wlodarczyk J, Murugasu R,. Presence of granulomas is associated with recurrence after surgery for Crohn's disease: experience of a surgical unit. Br J Surg. 1997; 84: 78-82. (Pubitemid 27033113)
34. Wolff BG,. Factors determining recurrence following surgery for Crohn's disease. World J Surg. 1998; 22: 364-369. (Pubitemid 28113523)
35. Whelan G, Farmer RG, Fazio VW, et al. Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology. 1985; 88: 1826-1833. (Pubitemid 15052294)
36. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an 'half elemental diet' as maintenance therapy for CD: a randomized-controlled trial. Aliment Pharmacol Ther. 2006; 24: 1333-1340. (Pubitemid 44571563)
37. Ogata H, Hibi T,. Does an elemental diet affect operation and/or recurrence rate in CD in Japan? J Gastroenterol. 2003; 38: 1019-1021. (Pubitemid 37455796)
38. Ikeuchi H, Kusunoki M, Yanagi H, et al. Effects of elemental diet (ED) on surgical treatment in CD. Hepatogastroenterology. 2000; 47: 390-392. (Pubitemid 30216298)